ACURX PHARMACEUTICALS INC (ACXP)

US00510M1045 - Common Stock

2.03  -0.01 (-0.49%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
14.58M12.09M12.82M4.60M5.93M
Research and Development
6.04M4.75M2.03M2.20M3.51M
Selling, General, and Administrative Expenses
8.53M7.34M10.78M2.40M2.42M
Operating Income
-14.58M-12.09M-12.82M-4.60M-5.93M
Non Recurring Items
N/A0.0070.00KN/AN/A
Income Before Taxes
-14.58M-12.09M-12.75M-4.60M-5.93M
Net Income
-14.58M-12.09M-12.75M-4.60M-5.93M
 
Per Share Data
EPS Diluted Total Ops
-1.15-1.12-1.49-0.48-0.62
Non GAAP EPS
-1.14N/AN/AN/AN/A
 
Statistics

All data in USD

Charts